Brainstorm Cell Therapeutics | BCLI - Ordinary Share Capital


Brainstorm Cell Therapeutics reported $11.04M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Mesoblast USD 1.29B 8.58M Dec/2025